Abstract: Described herein are compounds that are useful as protein kinase inhibitors, especially inhibitors of ERK, having the formula:
where A, B, R1, R2, T and Ht are described in the specification. The compounds are useful for treating diseases in mammals that are alleviated by a protein kinase inhibitor, particularly diseases such as cancer, inflammatory disorders, restenosis, and cardiovascular disease.
Type:
Grant
Filed:
September 14, 2001
Date of Patent:
December 17, 2002
Assignee:
Vertex Pharmaceuticals Incorporated
Inventors:
Michael Hale, James Janetka, Francois Maltais, Jingrong Cao, Robert Mashal